Clinical trial
An Open-Label Trial of Donepezil in Fragile X Syndrome
NCT00220584 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00220584 |
|---|---|
| Title | An Open-Label Trial of Donepezil in Fragile X Syndrome |
| Official title | An Open-Label Trial of Donepezil in Fragile X Syndrome |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Fragile X Syndrome |
| Intervention type | Drug |
| Interventions | donepezil |
| Enrollment | 10 |
| Start date | Jul 1, 2005 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 13, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: